SI1802571T1 - Postopek in intermediati za pripravo N benzhidril azetidin il N fenil metilsulfonamidnih derivatov - Google Patents

Postopek in intermediati za pripravo N benzhidril azetidin il N fenil metilsulfonamidnih derivatov

Info

Publication number
SI1802571T1
SI1802571T1 SI200531476T SI200531476T SI1802571T1 SI 1802571 T1 SI1802571 T1 SI 1802571T1 SI 200531476 T SI200531476 T SI 200531476T SI 200531476 T SI200531476 T SI 200531476T SI 1802571 T1 SI1802571 T1 SI 1802571T1
Authority
SI
Slovenia
Prior art keywords
methylsulphonamide
benzhydryl
azetidin
intermediates
phenyl
Prior art date
Application number
SI200531476T
Other languages
English (en)
Inventor
Philippe Boffelli
Michel Delthil
Luc Grondard
Maxime Lampilas
Joel Malpart
Stephane Mutti
Bouda Lahlou Nait
Joerg Rieke-Zapp
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of SI1802571T1 publication Critical patent/SI1802571T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
SI200531476T 2004-10-14 2005-10-10 Postopek in intermediati za pripravo N benzhidril azetidin il N fenil metilsulfonamidnih derivatov SI1802571T1 (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0410845A FR2876689B1 (fr) 2004-10-14 2004-10-14 Nouveau procede et intermediaires de preparation de derives de n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulfonamide

Publications (1)

Publication Number Publication Date
SI1802571T1 true SI1802571T1 (sl) 2012-03-30

Family

ID=34953744

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200531476T SI1802571T1 (sl) 2004-10-14 2005-10-10 Postopek in intermediati za pripravo N benzhidril azetidin il N fenil metilsulfonamidnih derivatov

Country Status (32)

Country Link
US (3) US7429668B2 (sl)
EP (1) EP1802571B1 (sl)
JP (1) JP4971986B2 (sl)
KR (1) KR20070063540A (sl)
CN (1) CN101039903A (sl)
AR (1) AR051389A1 (sl)
AT (1) ATE534624T1 (sl)
AU (1) AU2005293453A1 (sl)
BR (1) BRPI0516526A (sl)
CA (1) CA2581781A1 (sl)
CR (1) CR9008A (sl)
CY (1) CY1112390T1 (sl)
DK (1) DK1802571T3 (sl)
EA (2) EA012523B1 (sl)
ES (1) ES2378181T3 (sl)
FR (1) FR2876689B1 (sl)
HR (1) HRP20120168T1 (sl)
IL (1) IL182277A0 (sl)
MA (1) MA29005B1 (sl)
ME (1) ME01297B (sl)
MX (1) MX2007004483A (sl)
NO (1) NO20072431L (sl)
PL (1) PL1802571T3 (sl)
PT (1) PT1802571E (sl)
RS (1) RS52132B (sl)
SG (2) SG144921A1 (sl)
SI (1) SI1802571T1 (sl)
TN (1) TNSN07115A1 (sl)
TW (1) TW200626542A (sl)
UY (1) UY29165A1 (sl)
WO (1) WO2006040464A1 (sl)
ZA (1) ZA200703011B (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2925050B1 (fr) * 2007-12-14 2010-01-08 Sanofi Aventis Nouveau procede de preparation de derives d'azetidine
SI2448910T1 (sl) * 2009-06-29 2013-07-31 Merz Pharma Gmbh & Co. Kgaa Postopek za pripravo nerameksana
DK2448909T3 (da) * 2009-06-29 2013-07-15 Merz Pharma Gmbh & Co Kgaa Fremgangsmåde til fremstilling af 1-amino-1,3,3,5,5-pentamethylcyclohexan
CN107089918B (zh) * 2017-04-08 2020-06-16 迪嘉药业集团有限公司 一种盐酸二苯甲胺的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9714129D0 (en) * 1997-07-04 1997-09-10 Pfizer Ltd Azetidines
FR2805817B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
US6566356B2 (en) * 2000-03-03 2003-05-20 Aventis Pharma S.A. Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
FR2814678B1 (fr) * 2000-10-04 2002-12-20 Aventis Pharma Sa Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite

Also Published As

Publication number Publication date
SG144921A1 (en) 2008-08-28
IL182277A0 (en) 2007-07-24
FR2876689B1 (fr) 2008-02-22
BRPI0516526A (pt) 2008-09-09
US20100087414A1 (en) 2010-04-08
UY29165A1 (es) 2006-05-31
EA200801990A1 (ru) 2009-06-30
NO20072431L (no) 2007-07-04
CA2581781A1 (fr) 2006-04-20
EA012523B1 (ru) 2009-10-30
CR9008A (es) 2007-10-01
CN101039903A (zh) 2007-09-19
SG144920A1 (en) 2008-08-28
PT1802571E (pt) 2012-03-05
ATE534624T1 (de) 2011-12-15
MA29005B1 (fr) 2007-11-01
KR20070063540A (ko) 2007-06-19
RS52132B (en) 2012-08-31
PL1802571T3 (pl) 2012-04-30
ZA200703011B (en) 2009-09-30
US7652154B2 (en) 2010-01-26
AR051389A1 (es) 2007-01-10
JP4971986B2 (ja) 2012-07-11
EA200700842A1 (ru) 2007-08-31
AU2005293453A1 (en) 2006-04-20
HRP20120168T1 (hr) 2012-03-31
FR2876689A1 (fr) 2006-04-21
WO2006040464A1 (fr) 2006-04-20
US8071788B2 (en) 2011-12-06
ES2378181T3 (es) 2012-04-09
JP2008516931A (ja) 2008-05-22
US20070244084A1 (en) 2007-10-18
US7429668B2 (en) 2008-09-30
CY1112390T1 (el) 2015-12-09
DK1802571T3 (da) 2012-03-12
EP1802571B1 (fr) 2011-11-23
US20080312205A1 (en) 2008-12-18
ME01297B (me) 2013-12-20
EP1802571A1 (fr) 2007-07-04
TW200626542A (en) 2006-08-01
MX2007004483A (es) 2007-06-13
TNSN07115A1 (fr) 2008-06-02

Similar Documents

Publication Publication Date Title
IL191554A0 (en) Lactam compounds and methods of using the same
PL1802579T3 (pl) Pochodne 3-aryloaminopirydynowe
IL187303A0 (en) Methods of prepering 3 - cyano - quinolines and intermediates made thereby
IL183216A0 (en) Nepetalactams and n-substituted derivatives thereof
ZA200509103B (en) Process and intermediates for the preparation of 3-(amino)-3-cyclobutylmethyl-2-hydroxy-propionamideor salts thereof
EP1856006A4 (en) SIALON CERAMIC AND METHOD OF MANUFACTURE
IL223579A0 (en) Synthesis of amines and intermediates for the synthesis thereof
IL183217A0 (en) Dihydronepetalactams and n-substituted derivatives thereof
IL213615A0 (en) N-(5-substituted-2-nitrophenyl)amine derivatives and methods for the preparation of 6-substituted-1-methyl-1-h-benzimidazole derivatives utilizing the same
EP1946007A4 (en) ANDROSTERONE DERIVATIVES AND METHODS OF USE
HK1119953A1 (en) Process for the stereoselective preparation of (-)-halofenate and intermediates thereof
IL182277A0 (en) Method and intermediates for the preparation of derivatives of n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulphonamide
IL188898A0 (en) Processes for preparing pyrazol-o-glycoside derivatives and novel intermediates of said processes
PL366690A1 (en) New derivatives of 4,5,6,7-tetrabromobenzimidazole and method for their obtaining
ZA200804872B (en) Lactam compounds and methods of using the same
GB0423746D0 (en) Process and polymorphs prepared thereby
IL187832A0 (en) Methods and intermediates for the preparation of optionally radio- labeled imatinib
SI1622926T1 (sl) Nov postopek in intermediati za pripravo 17-halogen-19-nor-steroidnih spojin
IL181904A0 (en) Novel product, method and intermediates for the preparation of azetidine derivatives
ZA200803329B (en) Process for the stereoselective preparation of (-)-halofenate and intermediates thereof
PL371171A1 (pl) Nowe pochodne takryny i sposób ich otrzymywania
PL375859A1 (pl) Nowe N-podstawione pochodne 2-amino-4-nitroimidazolu oraz sposób ich otrzymywania
PL372012A1 (pl) Sposób wytwarzania chlorku N-metylonikotynamidu
EP1811022A4 (en) ARYLACYLAMIDASE GENE AND METHOD OF USE IDOINE
PL381202A1 (pl) Pochodne izochinolinowe i sposoby ich stosowania